Skip to main content
Clinical Trials/IRCT20221025056287N1
IRCT20221025056287N1CompletedPhase 2

Evaluation of the effectiveness of microneedling with Tranexamic acid in comparison with microneedling with PRP in the treatment of melasma

Ahvaz University of Medical Sciences0 sites23 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
23

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
Female

Inclusion Criteria

  • 18-50 years old women with Melasma
  • Symmetrical and bilateral facial Melasma

Exclusion Criteria

  • Pregnant women
  • Breastfeeding mothers
  • Use of anticoagulants and anticonvulsants
  • Being allergic to the study drugs and topical lidocaine
  • History of Melasma treatment during the past month
  • Active Herpes simplex lesions on the face
  • Facial warts
  • Any history of coagulation disorders and thrombotic problems

Investigators

Similar Trials